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Abstract 
Strongyloides stercoralis (SS) is a unique nematode with an auto infective cycle, so that 
it completes its life cycle within the human host and can live there for many years. 
In immunocompromised patients, infection can cause Strongyloides hyperinfection 
syndrome (S.H.S) that is associated with serious morbidity and mortality. As vari-
ous infections are one of the leading causes of membranoproliferative glomerulo-
nephritis (MPGN), we should consider subclinical strongyloidiasis as a possible 
underlying disease, especially in endemic areas. Here we describe a case of strongy-
loidiasis following immunosuppressive therapy for MPGN, the diagnosis of which 
was made, only a few hours before death, by stomach biopsy.  
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Introduction 
 
trongyloidiasis results from infection 
with Strongyloides Stercoralis (SS).The 
parasite can affect gastrointestinal, 
pulmonary, and dermatologic systems. 
Manifestations of the infection can range from 
asymptomatic eosinophilia in the immuno-
competent host to disseminated disease when 
immunosuppression is implemented. 
There are several case reports of dissemi-
nated strongyloidiasis among patients who 
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were receiving corticosteroid due to mem-
branoprolifative glomerulonephritis (MPGN) 
or other pathologies of nephrotic syndrome 
(1-5). 
Here we report a patient with Strongyloides 
hyperinfection syndrome (SHS) after a few 
months of immunosuppressive therapy for 
MPGN disease.  
 
Case presentation 
 
A 64 yr old man presented with vomiting and 
fever, from 2 weeks before admission to 
Hasheminejad Kidney Center (HKC) in Teh-
ran, Iran in 2008. He was well until 6 months 
before admission, when he was referred from 
a southern province of Iran (Khuzestan) to 
another nephrology center due to nephrotic 
range proteinuria. Kidney biopsy had been 
performed at that time and glomerular mem-
branoproliferative pattern was seen with cres-
cent formation in 5 out of 13 glomeruli. Two 
glomeruli also showed fibrinoid necrosis. 
Tubular atrophy and proportional interstitial 
fibrosis was seen in 20% of submitted tissue 
surface. The diagnosis of diffuse proliferative 
and necrotizing glomerulonephritis with cres-
cent formation was made with a suggestion of 
the background disease of Membranoprolifer-
ative Glomerulonephritis (Fig.1). 
He was treated with prednisolone, 60 mg 
daily that was gradually tapered to 15 mg per 
day, and cyclophosphamide 75 mg daily. He 
was receiving both drugs when he was admit-
ted to HKC. He was originally a resident of 
Khuzestan Province. In his past medical his-
tory, there was no positive finding of respira-
tory or gastrointestinal diseases. 
On his first physical examination, the patient 
showed no abnormal finding except for a low-
grade fever (37.8 ˚C). He appeared ill but had 
no respiratory distress, skin rash or lymphade-
nopathy. 
Laboratory data and imaging studies are pre-
sented in Table 1. 
 
Table 1: Laboratory data of the patient 
 
CBC WBC (eosinophil count:2%) 2*103/μl 
 Hg 8 g/dl 
 PLT 75*103/μl 
Blood Biochemistry BUN 109 mg/dl 
 Cr 6.5 mg/dl 
 K 6.7 mmol/L 
 Na 136 mmol/L 
Liver Enzymes SGOT Normal 
 SGPT Normal 
U/A blood 1+ 
 protein 1+ 
 WBC 2-3 
Serologic Tests ANA Normal 
 ANCA Negative 
 Complements(C3,C4,CH50) Normal 
Viral Markers  HBS Ag Negative 
 HCV Ab Negative 
Imaging   
 Chest X Ray Normal 
 Abdonimopelvic sonography Normal 
.  
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Fig. 1: Cellular crescent with endocapillary 
proliferation of the glomeurlus under light 
microscopy in favor of MPGN pattern, core 
biopsy of the patient’s kidney. This sample 
was obtained in Khuzestan and the blocks 
were reviewed in Pathology Unit, Hashemi-
nejad Kidney Center (Jones staining). Original 
picture 
 
Cyclophosphamie was discontinued, broad-
spectrum antibiotic therapy was started and 
hemodialysis was performed. One day after 
admission, upper gastrointestinal (GI) endos-
copy was performed, because of intractable 
vomiting which showed severe erythematous 
lesions in stomach mucosa. On third hospital 
day, his general condition deteriorated rapidly 
and the patient developed dyspnea. A chest 
CT scan demonstrated diffuse alveolar infil-
trates. He was intubated due to worsening of 
dyspnea and massive hemoptysis. Histological 
examination of gastric biopsy specimens re-
vealed numerous cross-sections of eggs and 
rhabditiform larvae of SS (Fig. 2). 
Treatment was started with ivermectin im-
mediately, however the patient died soon after, 
with massive alveolar hemorrhage and respira-
tory failure, on the fifth hospital day and only 
12 hours after the diagnosis of SHS. 
 
 
 
Fig. 2: Gastric mucosa of the patient showing 
inflammatory infiltration of lamina propria 
and eggs (A) and rhabditiform larvae (B) of 
Strongyloides stercoralis in the glands under light 
microscopy in a biopsy made by endoscopic 
procedure (H&E staining). Original picture 
 
Discussion  
 
Strongyloides stercoralis is an intestinal parasite 
affecting 100 million people worldwide. It is 
endemic in tropical and subtropical areas in 
the world (6-9). Diagnosis of latent infection 
is difficult due to limitations of current parasi-
tological and serological methods (10-15). In 
Iran, it is an endemic parasite especially in 
southern and Northern provinces. Jalali et al. 
reported a prevalence of 1.4% in north of Iran, 
whereas Farahnak reported a prevalence of 
6.9% in southern parts of Iran (6-7). In Ker-
manshah in 2004, out of 206 patients who 
were HIV positive, 2 (0.9%) had positive stool 
culture for SS (10). 
In immunosuppressed hosts, SS may be-
come invasive, causing SHS, which results 
from systemic dissemination of filariform lar-
vae (8-9). Defects in cell-mediated immunity 
and corticosteroid use are considered the ma-
jor risk factors for development of Strongyloides 
hyperinfection in immunocompromised hosts 
(17-18). Cruz and Rogers reported the first 
cases of SHS in 1966, as the occurrence of 
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fatal strongyloidiasis with immunosuppression 
(16-17). In Iran, there are few reports of SHS 
in patients who had acute or chronic lympho-
blastic leukemia (26-27). 
In a study, 103 previously described cases of 
presumed Strongyloides hyperinfection were re-
viewed. Among 89 patients, immunocompro-
mised by therapy or disease, the mortality rate 
was 86% (18). In endemic areas, most cases 
are infected with this nematode a long time 
before manifestation of the hyperinfection 
syndrome (18). 
In this case report, we present a case of ster-
oid and cyclophosphamide resistant MPGN 
complicated by disseminated strongyloidiasis 
who died 7 months after beginning of pro-
teinuria. 
There are many reports of association of 
parasitic infections and glomerulonephritis, 
however Strongyloides associated glomerulone-
phritis has not been well-defined (19-21). 
 Although SS can involve any organ directly, 
there is evidence that suggest that immunolog-
ical reactions can play a role in the pathogene-
sis of disease (22-24). Considering many re-
ports of remission of nephrotic syndrome af-
ter treatment of Strongyloides infection with an-
thelmintic agents, the possibility of Strogyloides 
related glomerulopathy is strengthened. 
 
Conclusion 
 
Regarding long persistence of SS in the human 
host after initial exposure and its potential to 
progression to disseminated strongyloidiasis in 
immunosuppressed patient from one hand and 
its high mortality rate from another hand, pa-
tients with risk factors for SS who are candidate 
for immunosuppressive therapy should be 
screened for disease. We also recommend 
screening for SS in patients who have nephrotic 
syndrome and live in endemic areas.  
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